201 results on '"Armstrong, Iain"'
Search Results
2. Exploratory and confirmatory factor analysis of emPHasis‐10: The health‐related quality‐of‐life measure in pulmonary hypertension
3. Pulmonary Hypertension: Intensification and Personalization of Combination Rx (PHoenix): A phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies
4. The Digital 1-Minute Walk Test: A New Patient-centered Cardiorespiratory Endpoint.
5. The impact of the Covid-19 pandemic on the lives of patients with pulmonary hypertension
6. A UK national patient survey of attitudes towards aspects of novel clinical trial design in pulmonary hypertension
7. Living with pulmonary hypertension – a cross-sectional survey of UK patients
8. A pilot study of a digital 1-Minute Walk Test as a novel decentralised endpoint in pulmonary hypertension research
9. A systematic review of psychological interventions in adults with pulmonary hypertension: Is the evidence‐base disproportionate to the problem?
10. Establishing minimally important differences for cardiac MRI end-points in pulmonary arterial hypertension
11. 154 Stability of daily physical activity as a remote measure of clinical risk in pulmonary arterial hypertension (pah)
12. 196 The relationship of physical activity, heart rate variability, and night heart rate to established measures of clinical risk in patients with pulmonary arterial hypertension (pah)
13. 153 Differences in physical activity, heart rate and heart variability during clinical worsening events in patients with pulmonary arterial hypertension (pah)
14. 138 Physiological detection of clinical worsening and therapeutic response using implanted remote technologies in pah
15. 158 Remote personalisation of pulmonary arterial hypertension therapy and application of a remote physiological risk score
16. 137 Design and validation of a physiological risk score for pulmonary arterial hypertension (pah)
17. Remote evaluation of risk and physiological response to therapeutic escalation and clinical worsening in patients with pulmonary hypertension
18. Can self‐compassion help us better understand the impact of pulmonary hypertension on those with the condition and their carers? A cross‐sectional analysis
19. Application and evaluation of high speed data transfer for decision support in remote health care
20. 33 Cardiac MRI thresholds for improvement in pulmonary arterial hypertension
21. What is the psychosocial burden of COVID‐19 on people with pulmonary hypertension?
22. Contributors
23. Quality of Life in Patients With Pulmonary Hypertension and Nursing in Adults With Congenital Heart Disease
24. The patient experience of pulmonary hypertension: a large cross-sectional study of UK patients
25. Cognitive and behavioral processes predict anxiety and depression in patients with pulmonary hypertension
26. Adults’ experiences of living with pulmonary hypertension: A thematic synthesis of qualitative studies
27. Coping styles associated with depression, health anxiety and health-related quality of life in pulmonary hypertension: cross-sectional analysis
28. Examining the impact of pulmonary hypertension on nonprofessional caregivers: A mixed‐methods systematic review
29. Long‐term outcomes of domiciliary intravenous iloprost in idiopathic and connective tissue disease‐associated pulmonary arterial hypertension
30. Self-help cognitive behavioural therapy for anxiety in pulmonary hypertension: pilot randomised controlled trial
31. Elective lower limb orthopaedic arthroplasty surgery in patients with pulmonary hypertension
32. Understanding of palliative care among people affected by Pulmonary Hypertension
33. The lived experiences of people shielding with pulmonary hypertension during the first wave of the COVID-19 pandemic
34. Adults' experiences of living with pulmonary hypertension: A systematic review and thematic synthesis of qualitative studies
35. Impact of living with pulmonary hypertension: A qualitative exploration
36. Maximal Exercise Testing Using the Incremental Shuttle Walking Test Can Be Used to Risk-Stratify Patients with Pulmonary Arterial Hypertension
37. Adults’ experiences of living with pulmonary hypertension: a thematic synthesis of qualitative studies
38. What is the psychosocial burden of COVID‐19 on people with pulmonary hypertension?
39. Percent-predicted incremental shuttle walking test distance stratifies risk in pulmonary arterial hypertension
40. EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multi-centre study
41. Patient information that promotes health literacy
42. Bone Pathology
43. Elective lower limb orthopedic arthroplasty surgery in patients with pulmonary hypertension.
44. EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre study
45. Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension
46. Unacceptable failures: the final report of the Lancet Commission into liver disease in the UK
47. Exploring a physiotherapy well-being review to deliver community-based rehabilitation in patients with pulmonary hypertension
48. Ventricular mass index correlates with pulmonary artery pressure and predicts survival in suspected systemic sclerosis-associated pulmonary arterial hypertension
49. Improved Outcomes in Medically and Surgically Treated Chronic Thromboembolic Pulmonary Hypertension
50. The incremental shuttle walk test predicts mortality in non-group 1 pulmonary hypertension: results from the ASPIRE Registry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.